Co-delivery of paclitaxel and survivin shRNA by pluronic P85-PEI/TPGS complex nanoparticles to overcome drug resistance in lung cancer
Author:
Publisher
Elsevier BV
Subject
Mechanics of Materials,Biomaterials,Biophysics,Ceramics and Composites,Bioengineering
Reference39 articles.
1. Annual report to the nation on the status of cancer, 1975–2005, featuring trends in lung cancer, tobacco use, and tobacco control;Jemal;J Natl Cancer Inst,2008
2. Multidrug resistance in cancer: role of ATP-dependent transporters;Gottesman;Nat Rev Cancer,2002
3. Mesoporous silica nanoparticles loading doxorubicin reverse multidrug resistance: performance and mechanism;Shen;Nanoscale,2011
4. Inhibition of topoisomerase I activity and efflux drug transporters' expression by xanthohumol from hops;Lee;Arch Pharm Res,2007
5. Multi-functional nanocarriers to overcome tumor drug resistance;Jabr-Milane;Cancer Treat Rev,2008
Cited by 136 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Trends in the synthetic polymer delivery of RNA;The Journal of Gene Medicine;2024-02
2. Optimized DOX Drug Deliveries via Chitosan-Mediated Nanoparticles and Stimuli Responses in Cancer Chemotherapy: A Review;Molecules;2023-12-20
3. Site-specific delivery of cisplatin and paclitaxel mediated by liposomes: A promising approach in cancer chemotherapy;Environmental Research;2023-12
4. Nanomedicine Combats Drug Resistance in Lung Cancer;Advanced Materials;2023-11-27
5. Delivery of Chemotherapy Agents and Nucleic Acids with pH-Dependent Nanoparticles;Pharmaceutics;2023-05-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3